Advances in epigenetic alterations of chronic lymphocytic leukemia: from pathogenesis to treatment
Open Access
- 16 March 2024
- journal article
- review article
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 24 (1) , 1-13
Abstract
Chronic lymphocytic leukemia (CLL) is a heterogeneous disease with alterations in genetic expression and epigenetic modifications. In recent years, the new insight into epigenetics in the pathogenesis of CLL has been developed considerably, including DNA methylation, histone modification, RNA methylation, non-coding RNAs as well as chromatin remodeling. Epigenetic modification regulates various processes such as stem cell biology, cell growth, and tumorigenesis without altering gene sequence. Growing evidence indicates that the disturbance of gene expression profiles which were regulated by epigenetic modifications exerts vital roles in the development and progress in CLL, which provides novel perspectives to explore the etiology of CLL. In addition, the integration with epigenetic therapeutic targets and the in-depth understanding of epigenetic therapy contribute to develop new therapeutic strategies for CLL. Herein, the present review discusses the advances of epigenetic alterations in the pathogenesis, diagnosis, and prognostic assessment of CLL patients and also highlights existing and emerging agents targeting epigenetic regulators.Keywords
Funding Information
- China Postdoctoral Science Foundation (No. 2022M721981)
- Shandong Provincial Natural Science Foundation (No.ZR2020QH094)
- National Natural Science Foundation (No.82000195, No.82270200, No.82070203 and No.81770210)
- Taishan Scholars Program of Shandong Province (No.tsqn201909184, No.tsqn201909184)
- Key Research and Development Program of Shandong Province (No.2018CXGC1213)
- Translational research grant of NCRCH (No.2021WWB02, No.2020ZKMB01)
- Shandong Provincial Engineering Research Center of Lymphoma
- Academic promotion programme of Shandong First Medical University (No.2019QL018)
This publication has 115 references indexed in Scilit:
- DAPK3 participates in the mRNA processing of immediate early genes in chronic lymphocytic leukaemiaMolecular Oncology, 2020
- Preclinical activity of the antibody‐drug conjugate denintuzumab mafodotin (SGN‐CD19A) against pediatric acute lymphoblastic leukemia xenograftsPediatric Blood & Cancer, 2019
- Novel positioning from obesity to cancer: FTO, an m6A RNA demethylase, regulates tumour progressionJournal of Cancer Research and Clinical Oncology, 2018
- Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemiaInternational Journal of Cancer, 2018
- LincRNa-p21: function and mechanism in cancerMedical Oncology, 2017
- Chronic Lymphocytic LeukemiaJAMA, 2014
- Association of a MicroRNA/TP53 Feedback Circuitry With Pathogenesis and Outcome of B-Cell Chronic Lymphocytic LeukemiaJAMA, 2011
- The novel histone deacetylase inhibitor, AR‐42, inhibits gp130/Stat3 pathway and induces apoptosis and cell cycle arrest in multiple myeloma cellsInternational Journal of Cancer, 2010
- Aberrant methylation of H‐cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinomaCancer, 2005
- Protein methylationCurrent Opinion in Cell Biology, 1993